Weight-Loss Drug Demand Fuels Boom in Hair Treatment Sales
UK chemists report significant increases in sales of hair care products and consultations as users seek to mitigate a common side effect of popular injectable medications.
The surging popularity of weight-loss drugs, such as Mounjaro and Wegovy, is driving a notable increase in the sales of hair treatment products and related consultations, according to major UK chemists Superdrug and Boots.
These injectable medications, designed to suppress appetite by making the body feel full, are now used by an estimated 1.9 million Britons. Approximately 6% of households report having at least one user, a substantial rise from 2.3% previously.
However, a common side effect reported by users is hair thinning or loss, leading to a growing demand for solutions. Superdrug noted a 14.9% increase in online doctor appointments for hair loss over the past year. Concurrently, sales of medicated hair care products have risen by 28.8% over two years, with specific hair treatments seeing a 27.7% increase since 2024, aligning with the heightened usage of these weight-loss injections.
Chelsey Saunders, director of haircare, skincare, and fragrance at Boots, observed a direct correlation between the growing conversations around GLP-1 medications and increased customer interest in hair and scalp health. "Concerns around thinning hair, shedding, and density have pushed customers to seek out targeted solutions," Saunders stated. "As a result, demand for efficacy-led products is accelerating."
Customers are increasingly focused on ingredients known to support hair health, such as keratin and collagen, with sales of these products rising. This trend mirrors a similar ingredient-led approach seen in the skincare market.
Social media also plays a significant role in driving purchasing decisions, with shoppers seeking out products and routines popularized by influencers and experts. The influence of trichologists, dermatologists, and pharmacists acting as online influencers is particularly notable, according to Saunders, leading to a surge in demand for specific, effective products.
This phenomenon highlights a direct consumer response to the side effects of a burgeoning pharmaceutical trend, demonstrating how emerging medical treatments can create ripple effects across related consumer markets.